Sandoz
About Sandoz
Certifications
Categories
-
AT
-
2017On CPHI since
-
4Certificates
-
5000+Employees
Company types
Primary activities
Meet us at
CPHI Barcelona 2023
Fira Barcelona Gran Via, Spain
24-26 October 2023
Products from Sandoz (3)
-
Product Finished Dosage Forms out-licensing & supply
Sandoz B2B offers a comprehensive portfolio of Finished Dosage Forms for out-licensing and supply, covering more than 20 therapeutic areas. We cover most major markets with our dossiers/marketing authorizations and are happy to discuss individual go-to market opportunities with you. Additionally, we of... -
Product Active Pharmaceutical Ingredients
Based on its longstanding history in Anti-Infectives, Sandoz B2B offers a range of beta-lactam antibiotics Intermediates and APIs. The portfolio includes products for oral preparations as well as for injectable use. We supply our products worldwide and assist our customers with the required documentati... -
Product Contract Manufacturing
Our Contract Manufacturing services provide access to production capabilities across multiple technology platforms, including solids, semi-solids and aseptics. Based on the global Novartis network of cGMP audited sites, we offer the full manufacturing cycle from bulk production via packaging and serial...
Sandoz Resources (6)
-
News Sandoz outlines European antibiotic manufacturing expansion
Novartis generics and biosimilars division will invest €150 million during the next 3-5 years at its Kundl, Austria and Palafolls, Spain sites while phasing out production of oral APIs at Les Franqueses site -
News Sandoz launches generic antibiotic Daptomycin in US
Sandoz Inc. announced the US market introduction of Daptomycin for injection 500 mg, an AP-rated generic version of Cubicin® (daptomycin)*, for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by Gram-positive bacteria and certain bloodstream infections, including right-sided infective endocarditis. -
News New collaboration between Novartis and Africa Medical Supplies Platform
New collaboration between Novartis and Africa Medical Supplies Platform to facilitate supply of COVID-19 related medicines. Novartis and the African Union (AU) through the Africa Medical Supplies Platform (AMSP) have announced a new collaboration to facilitate the supply of medicines from the Novartis Pandemic Response Portfolio to the AU member states and Caricom countries. -
News US biosimilars five years on: Life on Mars?
Richard Saynor on LinkedIn -
News Sandoz and Austrian government announce joint antibiotics manufacturing investment
Novartis' generics and biosimilars division, Sandoz, has announced a joint investment with the Austrian federal government worth over EUR 150 million to boost integrated antibiotics manufacturing in Europe. -
News Sandoz enters global deal to commercialise proposed biosimilar natalizumab
Worldwide agreement with Polpharma gives Sandoz commercialization rights to proposed biosimilar natalizumab for relapsing-remitting multiple sclerosis.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance